Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001209191-23-012924 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | HRTX | Morgan Adam | Dir, See Notes 2, 3 | A - Grant | $0.00 | +37.9K | 37.9K | New | $0 |
| D | 2023-02-24 | 2023-02-22 | HRTX | Morgan Adam | Dir, See Notes 2, 3 | A - Grant | $0.00 | +227.3K | 227.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | A | A | 37,879 | $0.00 | 37,879 | D | — | — | (F1) The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning three months after the date of grant (02/22/2023). |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-22 | A | A | 227,272 | $0.00 | 227,272 | D | $2.70 · — to 2033-02-22 | 227,272 Common Stock | (F4) The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023). |